UMANG PATEL: Open Payments
NPI 1265548077 · WOODRIDGE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 55 payments from 19 companies in 2025. Trend: 2023 $270 · 2024 $1,175 · 2025 $1,291
Food & beverage: $1,291
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $365 |
| AstraZeneca Pharmaceuticals LP | 11 | $350 |
| PFIZER INC. | 3 | $68 |
| Agios Pharmaceuticals, Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Eisai Inc. | 2 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
Products named: FARXIGA, MOUNJARO, JARDIANCE, KISUNLA, PYRUKYND, CAPLYTA, LEQVIO, REXULTI.
Industry payments across IL — which companies pay providers there.
